Heart Matters
Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more.
So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.
- Update frequency
- every 14 days
- Episodes
- 374
- Years Active
- 2008 - 2025
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
Guest: Ana Barac, MD, PhD
Cardio-oncology is a novel field in cardiovascular medicine that has rapidly grown over the past few years. What kind of role does multi…
The STELLAR Trial: Key Data on Sotatercept for PAH
A recent study explored the safety and efficacy of sotatercept on top of background pulmonary arterial hypertension (PAH) therapy. To learn more about this clinic…
The STELLAR Trial: Key Data on Sotatercept for PAH
A recent study explored the safety and efficacy of sotatercept on top of background pulmonary arterial hypertension (PAH) therapy. To learn more about this clinic…
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
Guest: Ana Barac, MD, PhD
Cardio-oncology is a novel field in cardiovascular medicine that has rapidly grown over the past few years. What kind of role does multi…
A Look at Lipoprotein(a): Key Screening & Treatment Strategies
According to the CDC, patients with familial hypercholesterolemia or patients who show signs of coronary heart disease are at an increased chance of having heart attack, stroke, and aortic stenosis d…
A Look at Lipoprotein(a): Key Screening & Treatment Strategies
According to the CDC, patients with familial hypercholesterolemia or patients who show signs of coronary heart disease are at an increased chance of having heart attack, stroke, and aortic stenosis d…
Anticipated Updates on Statin Intolerance at ACC 2023
Guest: Kevin C. Maki, PhD, FNLA, CLS
At the American College of Cardiology's 72nd Annual Scientific Session & Expo, cardiologists w…
Anticipated Updates on Statin Intolerance at ACC 2023
Guest: Kevin C. Maki, PhD, FNLA, CLS
At the American College of Cardiology's 72nd Annual Scientific Session & Expo, cardiologists w…
The Role of Implementation Science in Familial Hypercholesterolemia
Guest: Laney K. Jones, PharmD, MPH
Patients with familial hypercholesterolemia (FH) are at an increased risk of developing coronary…
The Role of Implementation Science in Familial Hypercholesterolemia
Guest: Laney K. Jones, PharmD, MPH
Patients with familial hypercholesterolemia (FH) are at an increased risk of developing coronary…
Updated Guidelines for Youth With Dyslipidemia
Guest: Lauren Williams, MCN,RD,LD
Kids with dyslipidemia don’t have much different nutritional needs than other young kids their ag…
Updated Guidelines for Youth With Dyslipidemia
Guest: Lauren Williams, MCN,RD,LD
Kids with dyslipidemia don’t have much different nutritional needs than other young kids their ag…
A Look into the Effectiveness of Dietary Supplements
Guest: Luke Laffin, MD
Six commonly used supplements thought to improve patients’ cholesterol may be doing more harm than good. So what do we need to know a…
A Look into the Effectiveness of Dietary Supplements
Guest: Luke Laffin, MD
Six commonly used supplements thought to improve patients’ cholesterol may be doing more harm than good. So what do we need to know a…
Uncovering the Results of the DELIVER Trial
Guest: Scott Solomon, MD
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction (DELIVER trial) is a study designed to assess the effec…
Uncovering the Results of the DELIVER Trial
Guest: Scott Solomon, MD
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction (DELIVER trial) is a study designed to assess the effec…
Exploring Novel Tools for PAH: Measuring Severity With a New Blood Test
Guest: Michael A. Solomon, MD, MBA
Guest: Sean Agbor-Enoh, MD, PhD
Pulmonary arterial hypertension (PAH) is a rare, and even fatal, condition that can i…
Exploring Novel Tools for PAH: Measuring Severity With a New Blood Test
Guest: Michael A. Solomon, MD, MBA
Guest: Sean Agbor-Enoh, MD, PhD
Pulmonary arterial hypertension (PAH) is a rare, and even fatal, condition that can i…
Investigating the Link Between PCOS & CV Risk Factors During Delivery
Guest: Erin Michos
Polycystic ovary syndrome (PCOS) affects approximately 5 to 13 percent of women in the general population. And although previous rese…
Investigating the Link Between PCOS & CV Risk Factors During Delivery
Guest: Erin Michos
Polycystic ovary syndrome (PCOS) affects approximately 5 to 13 percent of women in the general population. And although previous rese…